In order for the Ebola virus (EBOV) to hijack a cell, it must first “board” its intended mass replication vehicle. The biomechanics of this process have been elusive, hindering the development of potential clinical...
Each year there are nearly 11 million cases of typhoid, a disease that is spread through contaminated food, drink and water. Researchers at the University of Maryland School of Medicine are leading an international...
Scientists decipher protein structure after more than fifty years of research Viruses depend on host cells for replication, but how does a virus induce its host to transcribe its own genetic information alongside that...
A vaccine against the biggest bacterial killer on the planet is a step closer to being available with funding secured for preclinical trials. Professor James Paton, Director of the University of Adelaide’s Research...
For years, scientists have been trying to come up with a better way to protect people against tuberculosis, the disease caused by infection with the Mycobacterium tuberculosis (Mtb) bacteria. Texas Biomedical Research...
Killer immune cells that can fight all strains of influenza virus provide the potential for a universal, one-shot flu vaccine. In the battle against the flu, our ‘killer’ immune cells are like the body’s border control...
Early mutation in neutralizing antibody gives it flexibility to adapt to virus’s changes In the quest to develop an effective HIV vaccine, researchers have focused attention on identifying and targeting the region...
A new Ebola vaccine is safe to use and highly effective against the deadly virus, scientists say, following successful trials in Guinea and Sierra Leone. The scientists’ study, published in the Lancet, notes that...
In a study published in the journal ‘Cell Reports’, the research shows that the broad-spectrum effects of the Bacillus Calmette-Guerin (BCG) vaccine could be mediated by metabolic and epigenetic changes in white blood...
Researchers from The University of Texas Medical Branch at Galveston have developed the first vaccine for chikungunya fever made from an insect-specific virus that doesn’t have any effect on people, making the...